Clinical trial · Interventional
Triple Antigen vs Monoantigen Immunotherapy for Warts
Triple Intralesional Antigen Immunotherapy Versus Monoantigen in the Treatment of Multiple Recalcitrant Warts
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Warts can be resistant to treatment or return despite the use of many therapeutic modalities. Combining immunotherapy might contribute to better response rates, particularly in recalcitrant warts, which is a real therapeutic challenge. The purpose of this study was to assess the effectiveness and safety of a triple intralesional immunotherapy combination composed of PPD, Candida antigen and MMR versus either agent alone in the management of multiple recalcitrant warts.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Triple Intralesional Immunotherapy Combination in Multiple Recalcitrant Warts | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Intralesional antigen immunotherapy | Biological | — | UNRESOLVED |
Design
Arms and outcomes
Arms (4)
- type
- ACTIVE_COMPARATOR
- label
- purified protein derivative (PPD)
- description
- Group A
- interventionNames
- Biological: Intralesional antigen immunotherapy
- type
- ACTIVE_COMPARATOR
- label
- Candida antigen.
- description
- Group B
- interventionNames
- Biological: Intralesional antigen immunotherapy
- type
- ACTIVE_COMPARATOR
- label
- Measles, Mumps and Rubella vaccine (MMR).
- description
- Group C
- interventionNames
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 10 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * Multiple (\> 3 warts) recalcitrant (at least 6 months duration and who did not respond to at least 2 treatment modalities) warts of different sites, size and duration Exclusion Criteria: 1. Patients with acute febrile illness or past history of asthma. 2. Allergic skin disorders such as generalized eczema and urticaria. 3. Past history of meningitis or convulsions. 4. Pregnancy or lactation.
References
Publications (0)
Data not yet available